PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer

Background and Objectives: Although perioperative immunotherapy is implemented as a standard of care for resected non-small cell lung cancer (NSCLC), there is unmet need for predictive biomarkers as programmed death-ligand 1 (PD-L1) is not the perfect one. The functionality of tumour-infiltrating im...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicina (Kaunas, Lithuania) Jg. 60; H. 3; S. 482
Hauptverfasser:	Gurevičienė, Giedrė, Matulionė, Jurgita, Poškienė, Lina, Miliauskas, Skaidrius, Žemaitis, Marius
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland MDPI AG 01.03.2024 MDPI
Schlagworte:	B7-H1 Antigen - metabolism Biomarkers, Tumor - metabolism Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - surgery CD8-Positive T-Lymphocytes - metabolism Chemotherapy Chronic obstructive pulmonary disease FDA approval Health aspects Humans Immunotherapy Lung cancer Lung cancer, Non-small cell Lung diseases Lung Neoplasms - pathology Lymphocytes Lymphocytes, Tumor-Infiltrating - metabolism Medical equipment and supplies industry Medical prognosis Medical test kit industry Metastasis non-small cell lung cancer Prognosis programmed death-ligand 1 Radiation therapy Squamous cell carcinoma Statistical analysis T cells Tumor Microenvironment Tumors tumour microenvironment Lithuania United States United States > US non-small cell lung cancer programmed death-ligand 1 tumour microenvironment
ISSN:	1648-9144, 1010-660X, 1648-9144
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!